Elutia (ELUT) vs Genenta Science S.p.A. (GNTA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Elutia (ELUT) has outperformed Genenta Science S.p.A. (GNTA) over the past year, losing 6.9% versus a loss of 78.4%. Elutia is the larger company by market cap ($36.6 million vs $34.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELUT | GNTA |
|---|---|---|
| Share price | $0.8273 | $0.7101 |
| Market cap | $36.64M | $34.24M |
| 1-day change | +0.88% | -5.95% |
| YTD return | +19.38% | -52.34% |
| 1-year return | -6.94% | -78.35% |
| 5-year return | -84.82% | — |
| EPS (TTM) | $-0.64 | $-0.37 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.39 | $10.00 |
| 52-week low | $0.50 | $0.55 |
| Distance from 52-week high | -40.27% | -92.90% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +504.38% | — |
| Average volume | 185.82K | 61.46K |
| Shares outstanding | 44.29M | 48.22M |
| Employees | 25 | 9 |
| Sector | Healthcare | Industrials |
| Industry | Medical Devices | Conglomerates |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ELUT has outperformed GNTA by 71.4 percentage points over the past year.
- The two companies sit in different sectors: Elutia in Healthcare and Genenta Science S.p.A. in Industrials.
About Elutia
ELUT stock →Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiovascular.
Healthcare · Medical Devices · 25 employees
About Genenta Science S.p.A.
GNTA stock →Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors.
Industrials · Conglomerates · 9 employees
ELUT vs GNTA FAQ
Which is bigger, Elutia or Genenta Science S.p.A.?
Elutia (ELUT) is larger, with a market capitalization of $36.64M compared with $34.24M for Genenta Science S.p.A. (GNTA).
Which stock has performed better over the past year, ELUT or GNTA?
ELUT returned -6.94% over the past 12 months, compared with -78.35% for GNTA (price return, excluding dividends). Past performance does not predict future results.
Are Elutia and Genenta Science S.p.A. in the same industry?
No. Elutia is in the Healthcare sector, while Genenta Science S.p.A. is in Industrials.